华中农大首次鉴定到柑橘黄龙病致病因子SDE10,AI设计出″人工″抗性蛋白

世界农化网中文网报道:黄龙病是全球柑橘产业上最具毁灭性病害,由专性寄生于韧皮部的细菌(Candidatus Liberibacter spp.)引起。由于该病菌迄今无法获得离体纯培养,且生产中缺乏稳定抗病的种质资源,深入解析病原-寄主互作机制,已成为抗病品种创制和绿色防控技术研发的核心前提。

香草硫缩病醚——新型有机硫类抗病毒剂 / 植物免疫激活剂

香草硫缩病醚(vanisulfane)是贵州大学2016年研发的新型有机硫类抗病毒剂,其可看作是由香草醛(香兰素)为先导化合物通过引入双(2-羟乙基)二硫代乙缩醛片段得到的具有激活作物自身免疫功能的″免疫激活剂″。研究表明香草硫缩病醚对烟草花叶病毒、黄瓜花叶病毒和马铃薯Y病毒等植物病毒都有较好的抑制作用。2021年11月,贵州大学将香草硫缩病醚专利使用权授予海南正业,目前由海南正业进行产业化开发。

比利时Rainbow Crops完成970万欧元种子轮融资,加速AI多重基因编辑技术平台落地

世界农化网中文网报道:近日,比利时农业科技企业 Rainbow Crops 专注通过复杂农艺性状基因改造培育优质作物品种,该公司宣布完成 970 万欧元种子轮融资。本次融资超额认购,资金将用于升级企业依托人工智能的多重基因编辑技术能力、拓展平台适配作物品类,同时扩充科研与技术研发团队。

拜耳领投、农业AI基础设施公司Leaf Agriculture 获1300万美元融资

世界农化网中文网报道:近日,农业数据基础设施公司 Leaf Agriculture 宣布完成 1300万美元B轮融资。本轮融资由拜耳旗下影响力投资部门 Leaps by Bayer 与多家产业战略投资方共同领投。Leaf 表示,这笔资金将用于进一步扩大其农业数据管理平台能力,帮助农资、保险、农业零售、食品和可持续发展等企业构建AI驱动的农业应用。

粮油巨头跨界杀入生物肥料市场;多款微藻/多酚等生物刺激剂亮相;烟粉虱RNAi防控新突破

本周速览:本周生物资讯关注两条主线:国内,鲁花释放本土巨头跨界生物肥信号;海外,巴西生物制剂军团(Biotrop、EcoSolução、JCO Bioprodutos)持续输出新品与出海战绩,荷兰官方数据为温室生防市场提供权威背书。

Beauty brands turn to AI for personalization and production

AI is permeating innovation across global industries, regardless of sector or scale. Beauty players are responding by grasping for footing, integrating AI in various ways to stay in the relentless tech race.

Slutty Vegan Signs Franchise Deal for First Midwest Location in Detroit

Atlanta-based plant-based burger chain Slutty Vegan has signed a franchise agreement to open its first Michigan location, with the restaurant planned for the Corktown neighborhood of Detroit. According to the company, the site at 1441 W Elizabeth Street is expected to open later this year, pending the completion of buildout.

Danish Researchers Turn Rapeseed Oil Byproduct Into Gel-Like Protein

Scientists are betting on an underutilised waste product from the oil industry to sustainably meet consumers’ never-ending appetite for protein.

L’Oréal bets on digital-first India with Innovist majority stake

L’Oréal has signed an agreement to acquire a majority stake in Innovist, a digital-first Indian personal care house of brands. The strategic move is part of L’Oréal’s planned expansion in India’s fast-growing beauty industry. 

StockWatch: Positive Phase III Data Sells Investors on Intellia

A second positive Phase III data readout in two months is a major reason why Intellia Therapeutics (Nasdaq: NTLA) shares have soared more than 76% over the past six months—including a 29% surge this past week that followed the CRISPR gene editing therapy developer’s lead pipeline candidate lonvoguran ziclumeran (lonvo-z) meeting three key secondary endpoints in a pivotal study in patients with hereditary angioedema (HAE).